McCune Law Group Investigating Centessa Pharmaceuticals Over Investor Losses

Centessa Pharmaceuticals may have caused investor losses

McCune Law Group, McCune Wright Arevalo Vercoski Kusel Weck Brandt APC (MLG) is investigating the need to bring a class action lawsuit on behalf of investors who may have suffered losses after purchasing Centessa securities. According to complaints, Centessa Pharmaceuticals, which creates multiple drugs and medical products, allegedly made false/misleading statements about the efficacy and abilities of their products, driving up the value of shares. However, once the truth about the Centessa products emerged, share prices plummeted, forcing investors to take heavy losses. Investors have until November 28th, 2022, to file as lead plaintiff in this matter.

To read more about this case, view the press release here.

Take The Next Step

Schedule Your Free Consultation Today